companies / gate2brain-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-06-17 json
| total_raised | 7,560,0007.6M | ○ |
|---|---|---|
| founded | 2020 | |
| hq | Barcelona, Spain | |
| industry | unknown | |
| stage | null |
Biotech developing BBB-shuttle peptide technology to deliver drugs across the blood-brain barrier to treat pediatric brain tumours such as DIPG
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2026-06-16 | Funding round | 7,560,0007.6M | null | ○ |
cdnjs, cloudflare, core-js, doubleclick floodlight, google analytics, google tag manager, gsap, jquery 3.6.1, mysql, nginx, php, wordpress 6.1.10
| fact | status | src |
|---|---|---|
| Funding round, $7.6M | attributed | ○ |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-25latest_round: seed, $7.6M, 2026-06-16 → Funding round, $7.6M, 2026-06-16, ○ 2026-06-17 | latest_round | seed, $7.6M, 2026-06-16 → Funding round, $7.6M, 2026-06-16 | ○ 2026-06-17 |
Records begin 2026-09-24. all_changes